Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.52 |
| ▸ | DRD4 | P21917 | 4/20 | 0.49 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.44 |
| ▸ | SCN1A | P35498 | 1/20 | 0.44 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 3/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.42 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | SLC6A12 | P48065 | 1/20 | 0.40 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4431231 | 0.92 | SCN9A (0.46) | HRH3DRD4SCN9ASCN1ASCN5A | |
| SCHEMBL3664140 | 0.91 | HPGDS (0.42) | HRH3DRD4SCN9ASCN1ASCN5A | |
| SCHEMBL3663733 | 0.87 | SLC6A4 (0.43) | HRH3DRD4SCN9ASCN1ASCN5A | |
| SCHEMBL4427569 | 0.87 | HRH3 (0.51) | HRH3SCN9ASCN1ASCN5ASLC6A5 | |
| SCHEMBL3661167 | 0.84 | PRKAA2 (0.44) | HRH3SCN9ASCN1ASCN5ASLC6A5 | |
| SCHEMBL62036 | 0.84 | DRD4 (0.69) | DRD4SLC6A5SLC6A12SLC6A13 | |
| SCHEMBL10160230 | 0.83 | HRH3 (0.62) | HRH3DRD4SCN9ASLC6A5EPHX2 | |
| SCHEMBL3665644 | 0.80 | CHRM4 (0.43) | HRH3EPHX2 | |
| SCHEMBL62615 | 0.79 | HDAC4 (0.51) | HRH3DRD4SCN9ASLC6A5AR | |
| SCHEMBL61628 | 0.78 | DRD4 (0.78) | DRD4SLC6A5SLC6A12SLC6A13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2231666-A1 | CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS | Rigel Pharmaceuticals, Inc. (US) | 2010-09-29 | — | — | EP | claimed |
| WO-2009076631-A1 | CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS | RIGEL PHARMACEUTICALS, INC. (US) | 2009-06-18 | — | — | WO | claimed |